| Literature DB >> 29391435 |
David Martín-Mora1, Álvaro Ortega1, Francisco J Pérez-Maldonado1, Tino Krell1, Miguel A Matilla2.
Abstract
Chemotaxis toward organic acids has been associated with colonization fitness and virulence and the opportunistic pathogen Pseudomonas aeruginosa exhibits taxis toward several tricarboxylic acid intermediates. In this study, we used high-throughput ligand screening and isothermal titration calorimetry to demonstrate that the ligand binding domain (LBD) of the chemoreceptor PA2652 directly recognizes five C4-dicarboxylic acids with KD values ranging from 23 µM to 1.24 mM. In vivo experimentation showed that three of the identified ligands act as chemoattractants whereas two of them behave as antagonists by inhibiting the downstream chemotaxis signalling cascade. In vitro and in vivo competition assays showed that antagonists compete with chemoattractants for binding to PA2652-LBD, thereby decreasing the affinity for chemoattractants and the subsequent chemotactic response. Two chemosensory pathways encoded in the genome of P. aeruginosa, che and che2, have been associated to chemotaxis but we found that only the che pathway is involved in PA2652-mediated taxis. The receptor PA2652 is predicted to contain a sCACHE LBD and analytical ultracentrifugation analyses showed that PA2652-LBD is dimeric in the presence and the absence of ligands. Our results indicate the feasibility of using antagonists to interfere specifically with chemotaxis, which may be an alternative strategy to fight bacterial pathogens.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29391435 PMCID: PMC5795001 DOI: 10.1038/s41598-018-20283-7
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Differential Scanning Fluorimetry based high-throughput ligand screening of PA2652-LBD. Shown are Tm changes for each of the 95 compounds present in the Biolog PM1 compound array of carbon sources with respect to the Tm of the ligand-free protein of 45.5 °C. The dashed line indicates the threshold of 2 °C for significant hits.
Figure 2Isothermal titration calorimetry analysis of ligand binding to PA2652-LBD. (a) Titration with both malic acid isomers. (b) Titration with racemic mixtures of citramalic and methylsuccinic acids. The upper panels are the titration raw data for the injection of 9.6–14.4 μl aliquots of 1–2 mM ligand solution into 20–35 μM of protein. The lower panels are the integrated, dilution heat corrected and concentration normalized peak areas fitted with the “One binding site” model of ORIGIN.
Figure 3Summary of isothermal titration calorimetry studies. Shown are the structures of the five ligands that showed binding as well as of other compounds that were analysed but did not reveal binding. Dissociation constants are means and standard deviations from three experiments.
Figure 4Sedimentation velocity analytical ultracentrifugation analysis of PA2652-LBD. The sedimentation coefficient profile is shown for the protein at 20 µM in the absence and in presence of 1 mM L-malic acid. Values shown are expressed at the conditions of the experiment, namely at a temperature of 7 °C and PIPES buffer.
Figure 5Quantitative capillary chemotaxis assays of Pseudomonas aeruginosa PAO1 toward different organic acids. Data are means and standard deviations from three biological replicates conducted in triplicate. Data were corrected with the number of cells that swam into buffer containing capillaries (1713 ± 231).
Figure 6Quantitative capillary chemotaxis assays of Pseudomonas aeruginosa PAO1 and its mutant defective in PA2652 to different PA2652 chemoeffectors. In all cases, chemoeffectors were used at a final concentration of 10 mM. Data were corrected with the number of cells that swam into buffer containing capillaries (1565 ± 327). Data are means and standard deviations from three biological replicates conducted in triplicate.
Figure 7Attractants and antagonists compete for binding at PA2652-LBD in vitro. Isothermal titration calorimetry analysis of the binding of L-malic acid to PA2652-LBD in the absence and presence of 2 or 20 mM of the antagonists, citraconic and D,L-methylsuccinic acids. Upper panel: Titration raw data for the injection of 9.6 μl aliquots of 1 mM of L-malic acid into 20 μM of protein in the absence and presence of antagonists (present both in the injector syringe and sample cell). Lower panel: Integrated, dilution heat corrected and concentration normalized peak areas fitted with the “One binding site” model of ORIGIN. The apparent binding constants are listed in Supplementary Table S2.
Figure 8Antagonists reduce the magnitude of chemotaxis toward L-malic acid. Quantitative capillary chemotaxis assays of P. aeruginosa PAO1 toward 1 mM L-malic acid in the absence (black bars) and presence of different antagonist concentrations. Data are means and standard deviations from three biological replicates conducted in triplicate. Data were corrected with the number of cells that swam into buffer containing capillaries (4266 ± 1133).
Summary of information available on malate responsive chemoreceptors.
| Name | Species | Ligands | Binding mode | LBD typea | Predicted LBD locationb | Reference |
|---|---|---|---|---|---|---|
| PA2652 | L-malic, citramalic, citraconic, bromosuccinic and methylsuccinic acids | direct | sCACHE | periplasm | This work | |
| McpS (PP4658) | L-malic, oxalacetic, citric, isocitric, succinic, fumaric and butyric acids | direct | HBM | periplasm |
[ | |
| McpM (GenBank accession no. LC005239) | L-malic, D-malic, D-tartaric, succinic, and fumaric acids | unknown | 4HB | periplasm |
[ | |
| McpT (GenBank accession no. LC005228) | D-malic acid, D-tartaric and L-tartaric acids | unknown | 4HB | periplasm |
[ | |
| McfS (Pput_4520) | succinic, malic, citric and fumaric acids | unknown | HBM | periplasm |
[ | |
| McfR (Pput_0339) | succinic, malic and fumaric acids | unknown | 4HBB | periplasm |
[ | |
| McpS (Pfl01_0728) | L-malic and succinic acids | unknown | HBM | periplasm |
[ | |
| McpT (Pfl01_3768) | L-malic and succinic acids | unknown | sCACHE | periplasm |
[ | |
| CcmL (Tlp3) | chemoattractants: malic and fumaric acids, Ile, purine; chemorepellents: Lys, Arg, glucosamine, succinic acid, thiamine | direct | dCACHE | periplasm |
[ | |
| MCP2201 (CtCNB1_2201) | malic acid (inhibitor of taxis to other organic acids), oxaloacetic, citric, isocitric, α-ketoglutaric, succinic and fumaric acids | direct | 4HB | periplasm |
[ |
aBased on the Pfam database[86]
bBased o the prediction of TM region using the DAS algorithm[39].